Literature DB >> 18592034

Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?

Claudio N Soares1, Brook Zitek.   

Abstract

Throughout most of their lives, women are at greater risk for depression than men. Hormones and neurotransmitters share common pathways and receptor sites in areas of the brain linked to mood, particularly through the hypothalamic-pituitary-gonadal axis. It has been hypothesized that women presenting with episodes of depression associated with reproductive events (i.e., premenstrual, postpartum, menopausal transition) may be particularly prone to experiencing depression, in part because of a heightened sensitivity to intense hormonal fluctuations. The menopausal transition, for example, appears to represent a window during which some women might be more vulnerable to the development of first onset or recurrent depressive symptoms and major depressive episodes. In this review, we examine the association between hormone changes and increased risk of developing depression. Some of the underlying mechanisms that may contribute to such an increased risk are discussed critically, with a special emphasis on the events occurring during the menopausal transition. Last, we explore some of the clinical and therapeutic implications of hormone-modulated depression in women.

Entities:  

Keywords:  depression; estrogens; hormone replacement therapy; menopause; pregnancy. ; premenstrual syndrome

Mesh:

Substances:

Year:  2008        PMID: 18592034      PMCID: PMC2440795     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  152 in total

Review 1.  The role of serotonin in hot flushes.

Authors:  H H Berendsen
Journal:  Maturitas       Date:  2000-10-31       Impact factor: 4.342

2.  The menopausal transition.

Authors:  Nanette Santoro
Journal:  Am J Med       Date:  2005-12-19       Impact factor: 4.965

3.  Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study.

Authors:  K Yaffe; B Ettinger; A Pressman; D Seeley; M Whooley; C Schaefer; S Cummings
Journal:  Biol Psychiatry       Date:  1998-05-01       Impact factor: 13.382

4.  Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study.

Authors:  A Ahokas; J Kaukoranta; K Wahlbeck; M Aito
Journal:  J Clin Psychiatry       Date:  2001-05       Impact factor: 4.384

5.  Double-blind treatment of major depression with dehydroepiandrosterone.

Authors:  O M Wolkowitz; V I Reus; A Keebler; N Nelson; M Friedland; L Brizendine; E Roberts
Journal:  Am J Psychiatry       Date:  1999-04       Impact factor: 18.112

6.  Antidepressant response and well-being in pre-, peri- and postmenopausal women with major depressive disorder treated with fluoxetine.

Authors:  Paolo Cassano; Claudio N Soares; Cristina Cusin; Alessandra Mascarini; Lee S Cohen; Maurizio Fava
Journal:  Psychother Psychosom       Date:  2005       Impact factor: 17.659

7.  Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.

Authors:  Peter J Schmidt; Robert C Daly; Miki Bloch; Mark J Smith; Merry A Danaceau; Linda Simpson St Clair; Jean H Murphy; Nazli Haq; David R Rubinow
Journal:  Arch Gen Psychiatry       Date:  2005-02

8.  Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial.

Authors:  Mary F Morrison; Michael J Kallan; Thomas Ten Have; Ira Katz; Kathryn Tweedy; Michelle Battistini
Journal:  Biol Psychiatry       Date:  2004-02-15       Impact factor: 13.382

9.  Estrogen augments serotonergic activity in postmenopausal women.

Authors:  U Halbreich; N Rojansky; S Palter; H Tworek; P Hissin; K Wang
Journal:  Biol Psychiatry       Date:  1995-04-01       Impact factor: 13.382

10.  The Utian Quality of Life (UQOL) Scale: development and validation of an instrument to quantify quality of life through and beyond menopause.

Authors:  Wulf H Utian; Jeffrey W Janata; Sheryl A Kingsberg; Mark Schluchter; James C Hamilton
Journal:  Menopause       Date:  2002 Nov-Dec       Impact factor: 3.310

View more
  75 in total

1.  Progesterone reduces depressive behavior of young ovariectomized, aged progestin receptor knockout, and aged wild type mice in the tail suspension test.

Authors:  Cheryl A Frye
Journal:  J Psychopharmacol       Date:  2009-12-04       Impact factor: 4.153

2.  Gestational stress induces persistent depressive-like behavior and structural modifications within the postpartum nucleus accumbens.

Authors:  Achikam Haim; Morgan Sherer; Benedetta Leuner
Journal:  Eur J Neurosci       Date:  2014-10-31       Impact factor: 3.386

Review 3.  Addictive behaviors across the menstrual cycle: a systematic review.

Authors:  Kayla M Joyce; Kimberley P Good; Philip Tibbo; Jocelyn Brown; Sherry H Stewart
Journal:  Arch Womens Ment Health       Date:  2021-01-06       Impact factor: 3.633

Review 4.  Stress Cardiomyopathy Diagnosis and Treatment: JACC State-of-the-Art Review.

Authors:  Horacio Medina de Chazal; Marco Giuseppe Del Buono; Lori Keyser-Marcus; Liangsuo Ma; F Gerard Moeller; Daniel Berrocal; Antonio Abbate
Journal:  J Am Coll Cardiol       Date:  2018-10-16       Impact factor: 24.094

Review 5.  Depression in peri- and postmenopausal women: prevalence, pathophysiology and pharmacological management.

Authors:  Claudio N Soares
Journal:  Drugs Aging       Date:  2013-09       Impact factor: 3.923

6.  Personal history of major depression may put women at risk for premenstrual dysphoric symptomatology.

Authors:  Eynav E Accortt; Anya V Kogan; John J B Allen
Journal:  J Affect Disord       Date:  2013-06-22       Impact factor: 4.839

7.  Estradiol Modulates Neural and Behavioral Arousal in Women With Posttraumatic Stress Disorder During a Fear Learning and Extinction Task.

Authors:  Anneliis Sartin-Tarm; Marisa C Ross; Anthony A Privatsky; Josh M Cisler
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-04-30

8.  Acupuncture treatment modulates the corticostriatal reward circuitry in major depressive disorder.

Authors:  Zengjian Wang; Xiaoyun Wang; Jian Liu; Jun Chen; Xian Liu; Guangning Nie; Kristen Jorgenson; Ki Cheul Sohn; Ruiwang Huang; Ming Liu; Bo Liu; Jian Kong
Journal:  J Psychiatr Res       Date:  2016-09-16       Impact factor: 4.791

Review 9.  Maternally responsive neurons in the bed nucleus of the stria terminalis and medial preoptic area: Putative circuits for regulating anxiety and reward.

Authors:  Jenna A McHenry; David R Rubinow; Garret D Stuber
Journal:  Front Neuroendocrinol       Date:  2015-04-21       Impact factor: 8.606

Review 10.  Polymorphisms of estrogen receptors and risk of depression: therapeutic implications.

Authors:  Joanne Ryan; Marie-Laure Ancelin
Journal:  Drugs       Date:  2012-09-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.